Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 186 Carcinoma, Non-Small-Cell Lung 144 Multiple Myeloma 120 Prostatic Neoplasms 118 Leukemia, Myeloid, Acute 77 Neoplasms 75 Colorectal Neoplasms 75 Melanoma 72 Neoplasm Metastasis 66 Lymphoma 66 Squamous Cell Carcinoma of Head and Neck 64 Lung Neoplasms 64 Pancreatic Neoplasms 54 Ovarian Neoplasms 50 Sarcoma 46 Carcinoma, Renal Cell 45 Triple Negative Breast Neoplasms 43 Glioblastoma 42 Urinary Bladder Neoplasms 41 Leukemia, Lymphocytic, Chronic, B-Cell 41 Carcinoma, Hepatocellular 41 Recurrence 40 Head and Neck Neoplasms 38 Hematologic Neoplasms 37 Lymphoma, Large B-Cell, Diffuse 36 Precursor Cell Lymphoblastic Leukemia-Lymphoma 35 Myelodysplastic Syndromes 35 Lymphoma, Non-Hodgkin 34 Brain Neoplasms 34 Lymphoma, Mantle-Cell 31

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Active not recruiting × Fever × Clear all

NCT01972347 2025-12-16

Neo Combi

Melanoma Institute Australia

Phase 2 Active not recruiting

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡